[帕罗西汀治疗双相障碍抑郁期的疗效和耐受性]。

IF 0.7 Q3 Medicine

Minerva Psichiatrica Pub Date : 1996-06-01

L A Ambrosio, D Buccomino, A Filippo, A Morelli, R Musacchio, F Pupo, F E Romano, G Marchese, E Barrese

{"title":"[帕罗西汀治疗双相障碍抑郁期的疗效和耐受性]。","authors":"L A Ambrosio, D Buccomino, A Filippo, A Morelli, R Musacchio, F Pupo, F E Romano, G Marchese, E Barrese","doi":"","DOIUrl":null,"url":null,"abstract":"Eighty patients aged between 20-65 years and suffering from bipolar disease according to DSM IV criteria, were treated with paroxetine for os at the single dosage of 20-40 mg/die. At regular intervals psychometric reagents were administered for the evaluation and the variations in the bipolar disease. Tolerability was excellent and side-effects mild, with a tendency to regress after the second week of therapy. The clinical assessment and the psychometric findings both suggest that paroxetina has a useful action on the bipolar disease.","PeriodicalId":42192,"journal":{"name":"Minerva Psichiatrica","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"1996-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Efficacy and tolerability of paroxetine in the treatment of the depressive phase of bipolar disorders].\",\"authors\":\"L A Ambrosio, D Buccomino, A Filippo, A Morelli, R Musacchio, F Pupo, F E Romano, G Marchese, E Barrese\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Eighty patients aged between 20-65 years and suffering from bipolar disease according to DSM IV criteria, were treated with paroxetine for os at the single dosage of 20-40 mg/die. At regular intervals psychometric reagents were administered for the evaluation and the variations in the bipolar disease. Tolerability was excellent and side-effects mild, with a tendency to regress after the second week of therapy. The clinical assessment and the psychometric findings both suggest that paroxetina has a useful action on the bipolar disease.\",\"PeriodicalId\":42192,\"journal\":{\"name\":\"Minerva Psichiatrica\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.7000,\"publicationDate\":\"1996-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Minerva Psichiatrica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Psichiatrica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

80例年龄在20-65岁之间，根据DSM IV标准患有双相情感障碍的患者，以20- 40mg /例的单剂量帕罗西汀治疗10年。定期使用心理测量试剂进行评估和双相情感障碍的变化。耐受性极好，副作用轻微，治疗第二周后有消退的趋势。临床评估和心理测量结果都表明帕罗西汀对双相情感障碍有有益的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[Efficacy and tolerability of paroxetine in the treatment of the depressive phase of bipolar disorders].

Eighty patients aged between 20-65 years and suffering from bipolar disease according to DSM IV criteria, were treated with paroxetine for os at the single dosage of 20-40 mg/die. At regular intervals psychometric reagents were administered for the evaluation and the variations in the bipolar disease. Tolerability was excellent and side-effects mild, with a tendency to regress after the second week of therapy. The clinical assessment and the psychometric findings both suggest that paroxetina has a useful action on the bipolar disease.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Minerva Psichiatrica PSYCHIATRY-

CiteScore

1.10

自引率

0.00%

发文量

期刊介绍： The journal Minerva Psichiatrica publishes scientific papers on psychiatry, psycology and psycopharmacology. Manuscripts may be submitted in the form of editorials, original articles, review articles, case reports, therapeutical notes, special articles and letters to the Editor. Manuscripts are expected to comply with the instructions to authors which conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Editors by the International Committee of Medical Journal Editors (www.icmje.org). Articles not conforming to international standards will not be considered for acceptance.